NCT00505219View on ClinicalTrials.gov

Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2010

Conditions
Osteonecrosis
Interventions
BIOLOGICAL

Ixmyelocel-T

Core decompression of the femoral head to remove necrotic tissue with Ixmyelocel-T given to treatment arm only.

OTHER

Standard of Care Only

Core decompression of the femoral head to remove necrotic tissue

Trial Locations (3)

11220

Lutheran Medical Center, Brooklyn

21215

Sinai Hospital of Baltimore, Baltimore

55455

University of Minnesota Department of Orthopaedic Surgery, Minneapolis

All Listed Sponsors
lead

Vericel Corporation

INDUSTRY

NCT00505219 - Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head | Biotech Hunter | Biotech Hunter